Expelled DNA that traps toxins may backfire in obese

June 18, 2013 by Carly Hodes, Cornell University
Expelled DNA that traps toxins may backfire in obese
Fat cells, an excess of which can produce an inflammatory environment that promotes disease.

(Medical Xpress)—The body's most powerful immune cells may have a radical way of catching their prey that could backfire on people who are overweight and others at risk for cancer, diabetes and chronic inflammation, suggests a new Cornell study.

The research describes the phenomenon and its potential cause, why it may threaten health and how to use this knowledge to develop new therapies for an array of diseases. It was published in Frontiers in Immunology this past spring.

The study is the first to show that the DNA of macrophages, the biggest , can unravel and move outside the cell to snag invading pathogens. Called extracellular traps, these sticky DNA remnants can occur anywhere, but the study found a troubling number inside rafts of macrophages surrounding dead in .

In that extracellular environment, the traps feed a of inflammation, increasing risk of several major diseases, the scientists predict. Uncovering what causes macrophage DNA to unravel, the study included a description indicating new preventative therapies for these diseases may be near at hand.

"Our collaborator, Paul Thompson at Scripps, has developed a new drug that we have shown can block trap formation and by inhibiting the process that triggers macrophage DNA to unravel and become traps," said Scott Coonrod, associate professor at the Baker Institute for at Cornell, who oversaw the study. "We envision someday using this new drug as a for cancer and other inflammation-related diseases."

A chemical event called hyper-citrillunation appears to cause extracellular trap formation, according to Coonrod's findings. It occurs when histones, which pack DNA into the nucleus, lose their electrical attraction to DNA, causing the roughly 2-meters-worth of DNA to be propelled outside the cell. While these traps normally help to clean up bacteria following infections, they also have a dark side. They are increasingly being found in diseases that do not have an infectious component, suggesting that, in some cases, traps may actually promote disease progression.

Expelled DNA that traps toxins may backfire in obese
A macrophage reaches out and ingests bacteria.

Breast cancer presents a particular concern for people who are overweight, said Coonrod's Dr. Andrew Dannenberg at Weill Cornell Medical College. Dannenberg's team was the first to find crown-like-structures (CLS), donut-shaped chunks of dead fat cells that are surrounded by macrophages, in human breasts. Dannenberg's work suggests that these structures release inflammatory signals that increase the risk of breast cancer.

"One of ' jobs is to clean up dead cells," said Coonrod. "When they come to sites with CLS to vacuum up the dead fat, the environment is full of inflammatory chemicals that promote trap formation. We looked at CLS lesions in breast tissue to see if macrophage traps were there. Our initial findings suggest that they are."

Inflammation plays a large role in the development of cancer. The Coonrod group is currently looking into the possibility that trap production in CLS lesions promotes inflammation.

"While still in the early stages, these findings are exciting because we have a drug that can block trap production," said Coonrod. "One could imagine that our anti-trap drug might be used one day to prevent disease by suppressing inflammation in inflammatory environments, such as breast tissue in women who are obese, thereby preventing disease progression."

The research "Identification of Macrophage Extracellular Trap-Like Structures in Mammary Gland Adipose Tissue: A Preliminary Study," was published in March.

Explore further: Mechanisms regulating inflammation associated with type 2 diabetes, cancer identified

Related Stories

Mechanisms regulating inflammation associated with type 2 diabetes, cancer identified

March 1, 2013
A study led by researchers at Boston University School of Medicine (BUSM) has identified epigenetic mechanisms that connect a variety of diseases associated with inflammation. Utilizing molecular analyses of gene expression ...

Atherosclerosis: Specific microRNAs promote inflammation

March 22, 2013
(Medical Xpress)—Atherosclerosis, an inflammatory reaction, is at the root of the most common forms of cardiovascular disease. Researchers at Ludwig-Maximilians-Universitaet in Munich have now identified a microRNA that ...

Review: inflammation's role in obesity-colorectal cancer link

September 13, 2012
(HealthDay)—A new review summarizes the ways in which inflammation and altered metabolism are associated with colorectal cancer in obese individuals; the review was published online Sept. 3 in Obesity Reviews.

Immune cells can be altered to help fight inflammatory diseases, research finds

October 11, 2012
(Medical Xpress)—A fundamental mechanism controlling cells of the human immune system could be key to helping fight inflammatory diseases such as rheumatoid arthritis and psoriasis, new research at the University of Dundee ...

Scientists uncover protective influence of Vitamin A against inflammatory bowel disease

June 5, 2013
Scientists at Trinity College Dublin have made novel discoveries around the protective influence of Vitamin A against the damaging immune responses that lead to inflammatory bowel disease. The research led by Professor of ...

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.